IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management V, LLC

Q1 2026 Holdings

Filed 2026-05-15 | 9 holdings | $271.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alumis Inc.(ALMS)COM022307102$129.9M5,896,99547.9%
CG Oncology, Inc.(CGON)COM156944100$68.0M1,004,05025.1%
Disc Medicine, Inc.(IRON)COM254604101$23.9M374,0698.8%
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$15.3M738,1515.7%
Eikon Therapeutics, Inc.(EIKN)COM282564103$14.0M1,318,9835.1%
Lyell Immunopharma, Inc.(LYEL)COM55083R203$9.6M477,0783.5%
Pharvaris N.V.(PHVS)COMN69605108$5.5M194,1252.0%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$4.1M265,0001.5%
Maze Therapeutics, Inc.(MAZE)COM578784100$773.3K25,9050.3%